Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

Experts said Trump’s action could potentially lower the cost of prescription drugs, perhaps by the 30 percent to 80 percent scale Trump said, but they cautioned that the order’s required procedural ...

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

Remarkably many of the drugs, including pembrolizumab, were not available throughout much of that period – yet ... did not factor in the cost of research and development, but Global Justice ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...